Lack of Materiality Fatal at Second Circuit
The Second Circuit affirmed a lower court’s dismissal of a qui tam case alleging that a pharmaceutical manufacturer misrepresented its compliance with good manufacturing practices to obtain FDA approval for its plant.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.